Inclusion of Adolescents in STI/HIV Biomedical Prevention Trials: Autonomy, Decision Making, and Parental Involvement

Susan L. Rosenthal, Marilyn C. Morris, Lily F. Hoffman, Gregory Zimet

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Adolescents, despite their disproportionate burden of disease, often are excluded from sexually transmitted infection and HIV biomedical prevention clinical trials. The 3 principles of the Belmont Report (justice, respect for persons, and beneficence, U.S. Department of Health and Human Services, 1979) can inform our understanding of the ethical imperative to include minors in these trials. Investigators and institutional review boards need to have an understanding of what constitutes no more than minimal risk, that is, what is part of adolescent well-child care. Although cognitive development extends into the young adult years, evidence suggests that in most situations research decision-making capacity of an older minor is similar to that of a young adult. Depending on the specifics of the study, parental involvement may range from parental consent while protecting confidentiality to adolescent self-consent with a waiver of parental consent. Regardless of the level of parental involvement, protection of adolescents enrolled in trials will require strategies that guard against the risk of accidental loss of confidentiality. We outline a number of ways in which pediatric psychologists can assist clinical trial investigators and institutional review boards to ethically recruit and enroll minors into biomedical prevention trials. Furthermore, a pediatric psychologist can contribute to needed research on adolescent decision making and parental involvement to develop more sophisticated approaches to involving minors in HIV and sexually transmitted infection biomedical clinical trials.

Original languageEnglish (US)
JournalClinical Practice in Pediatric Psychology
DOIs
StateAccepted/In press - May 24 2018

Fingerprint

Sexually Transmitted Diseases
Decision Making
Minors
HIV
Parental Consent
Research Ethics Committees
Confidentiality
Clinical Trials
Young Adult
Research Personnel
Pediatrics
United States Dept. of Health and Human Services
Psychology
Beneficence
Social Justice
Child Care
Research

Keywords

  • Adolescents
  • Clinical trials
  • HIV infection and AIDS
  • Research ethics
  • Sexually transmitted infections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Clinical Psychology
  • Applied Psychology

Cite this

Inclusion of Adolescents in STI/HIV Biomedical Prevention Trials : Autonomy, Decision Making, and Parental Involvement. / Rosenthal, Susan L.; Morris, Marilyn C.; Hoffman, Lily F.; Zimet, Gregory.

In: Clinical Practice in Pediatric Psychology, 24.05.2018.

Research output: Contribution to journalArticle

@article{51df3a68150b492e97eec69b5000b47b,
title = "Inclusion of Adolescents in STI/HIV Biomedical Prevention Trials: Autonomy, Decision Making, and Parental Involvement",
abstract = "Adolescents, despite their disproportionate burden of disease, often are excluded from sexually transmitted infection and HIV biomedical prevention clinical trials. The 3 principles of the Belmont Report (justice, respect for persons, and beneficence, U.S. Department of Health and Human Services, 1979) can inform our understanding of the ethical imperative to include minors in these trials. Investigators and institutional review boards need to have an understanding of what constitutes no more than minimal risk, that is, what is part of adolescent well-child care. Although cognitive development extends into the young adult years, evidence suggests that in most situations research decision-making capacity of an older minor is similar to that of a young adult. Depending on the specifics of the study, parental involvement may range from parental consent while protecting confidentiality to adolescent self-consent with a waiver of parental consent. Regardless of the level of parental involvement, protection of adolescents enrolled in trials will require strategies that guard against the risk of accidental loss of confidentiality. We outline a number of ways in which pediatric psychologists can assist clinical trial investigators and institutional review boards to ethically recruit and enroll minors into biomedical prevention trials. Furthermore, a pediatric psychologist can contribute to needed research on adolescent decision making and parental involvement to develop more sophisticated approaches to involving minors in HIV and sexually transmitted infection biomedical clinical trials.",
keywords = "Adolescents, Clinical trials, HIV infection and AIDS, Research ethics, Sexually transmitted infections",
author = "Rosenthal, {Susan L.} and Morris, {Marilyn C.} and Hoffman, {Lily F.} and Gregory Zimet",
year = "2018",
month = "5",
day = "24",
doi = "10.1037/cpp0000209",
language = "English (US)",
journal = "Clinical Practice in Pediatric Psychology",
issn = "2169-4826",
publisher = "American Psychological Association Inc.",

}

TY - JOUR

T1 - Inclusion of Adolescents in STI/HIV Biomedical Prevention Trials

T2 - Autonomy, Decision Making, and Parental Involvement

AU - Rosenthal, Susan L.

AU - Morris, Marilyn C.

AU - Hoffman, Lily F.

AU - Zimet, Gregory

PY - 2018/5/24

Y1 - 2018/5/24

N2 - Adolescents, despite their disproportionate burden of disease, often are excluded from sexually transmitted infection and HIV biomedical prevention clinical trials. The 3 principles of the Belmont Report (justice, respect for persons, and beneficence, U.S. Department of Health and Human Services, 1979) can inform our understanding of the ethical imperative to include minors in these trials. Investigators and institutional review boards need to have an understanding of what constitutes no more than minimal risk, that is, what is part of adolescent well-child care. Although cognitive development extends into the young adult years, evidence suggests that in most situations research decision-making capacity of an older minor is similar to that of a young adult. Depending on the specifics of the study, parental involvement may range from parental consent while protecting confidentiality to adolescent self-consent with a waiver of parental consent. Regardless of the level of parental involvement, protection of adolescents enrolled in trials will require strategies that guard against the risk of accidental loss of confidentiality. We outline a number of ways in which pediatric psychologists can assist clinical trial investigators and institutional review boards to ethically recruit and enroll minors into biomedical prevention trials. Furthermore, a pediatric psychologist can contribute to needed research on adolescent decision making and parental involvement to develop more sophisticated approaches to involving minors in HIV and sexually transmitted infection biomedical clinical trials.

AB - Adolescents, despite their disproportionate burden of disease, often are excluded from sexually transmitted infection and HIV biomedical prevention clinical trials. The 3 principles of the Belmont Report (justice, respect for persons, and beneficence, U.S. Department of Health and Human Services, 1979) can inform our understanding of the ethical imperative to include minors in these trials. Investigators and institutional review boards need to have an understanding of what constitutes no more than minimal risk, that is, what is part of adolescent well-child care. Although cognitive development extends into the young adult years, evidence suggests that in most situations research decision-making capacity of an older minor is similar to that of a young adult. Depending on the specifics of the study, parental involvement may range from parental consent while protecting confidentiality to adolescent self-consent with a waiver of parental consent. Regardless of the level of parental involvement, protection of adolescents enrolled in trials will require strategies that guard against the risk of accidental loss of confidentiality. We outline a number of ways in which pediatric psychologists can assist clinical trial investigators and institutional review boards to ethically recruit and enroll minors into biomedical prevention trials. Furthermore, a pediatric psychologist can contribute to needed research on adolescent decision making and parental involvement to develop more sophisticated approaches to involving minors in HIV and sexually transmitted infection biomedical clinical trials.

KW - Adolescents

KW - Clinical trials

KW - HIV infection and AIDS

KW - Research ethics

KW - Sexually transmitted infections

UR - http://www.scopus.com/inward/record.url?scp=85047324608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047324608&partnerID=8YFLogxK

U2 - 10.1037/cpp0000209

DO - 10.1037/cpp0000209

M3 - Article

AN - SCOPUS:85047324608

JO - Clinical Practice in Pediatric Psychology

JF - Clinical Practice in Pediatric Psychology

SN - 2169-4826

ER -